This thematic ETF tracks the ARK Israel Innovation Index and invests in innovative technology companies headquartered in Israel. It holds companies across several innovation areas, including genomics, biotech, industrials, and information technology, on an equal-weighted basis to ease concentration in particular stocks.

It suits investors who want concentrated regional exposure to the Israeli innovation technology theme and prefer equal-weighted diversification.

It is a passive (index-tracking) ETF managed by ARK Invest.

The fund uses an indexing approach that replicates the index constituents, holding Israeli innovation companies on an equal-weighted basis. Unlike market-cap weighting, it keeps position sizes similar across stocks to reduce large-cap concentration, and it resets the equal-weighted composition through quarterly rebalancing.

• Regional theme exposure specialized in Israeli innovation companies
• Equal-weighted composition rather than market-cap weighting

Assets under management (AUM) stand at $120.5M, and the total expense ratio is 0.49% per year.

What sets it apart from broad AI and technology theme ETFs is its focus on a single region and equal weighting.

The fund has shown volatility that varies with the innovation technology theme and conditions in the Israeli market, and its short-term performance tends to depend on technology sector sentiment and regional risk. Because of the equal-weighted structure, its movements reflect the overall portfolio rather than one or two large stocks.

As a region-specific thematic ETF, its fund flows tend to depend on investment demand for the Israeli market and the innovation technology sector. Compared with broad core ETFs, the category is relatively small, so inflows and outflows can swing as interest in the theme shifts.

Its strengths are concentrated exposure to the Israeli innovation theme and equal-weighted diversification, while its main weakness is volatility stemming from regional and thematic concentration.

AIQ, ARTY, CHAT, and others shown in the table are ETFs with exposure to the broad artificial intelligence and technology themes, and they differ from IZRL in that they are widely diversified rather than limited to a specific country. For a direct substitute that tracks the same Israeli technology theme, products such as ITEQ can be compared side by side, and for broader exposure to genomics and innovation themes, a broad innovation ETF such as ARKK is also worth a look.

Here are the points to review before investing in IZRL. Because it is a regional theme ETF, it is wise to confirm in advance its single-country concentration, costs, equal-weighted structure, and currency exposure. Keep in mind that it is a thematic product with a different character from broad core ETFs.

Single-country concentration and the volatility of the innovation technology theme are the main drivers of short-term swings. When region-specific political or economic events occur, the diversification benefit may be limited, so position sizing needs to be managed.

It is a suitable choice for investors who want to concentrate on the Israeli innovation technology theme. If you want a broader technology theme, consider broad ETFs such as AIQ and ARTY, and if you want to compare the same Israeli technology theme, it is recommended to review a direct substitute such as ITEQ alongside it.